Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US11707610B2 · kind B2 · utility
0Cited by
50References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2020 |
| Grant date | Jul 25, 2023 |
| Priority date | — |
| Expiry date | Dec 11, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/1042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.